ABOUT MEDABLE
Medable is on a mission to get effective therapies to people faster while expanding clinical research access to everybody, eliminating critical barriers to participation such as income status, geography, & race. Their next-generation AI-powered trial platform is built for speed, control, and global scale, with unmatched experiences for study teams, sites, and patients.
Founded by visionary CEO Dr. Michelle Longmire after discovering firsthand the difficulties of finding clinical operations, Medable’s platform is designed by a combination of physicians, patients, and tech experts to deliver true impact. The result is over 400 decentralized trials conducted across 70+ countries and 120+ locales with over 1 million patients supported globally.
A pioneer in patient-centric trials, Medable was ranked the number one provider of decentralized clinical trials (DCTs) and a Leader in eCOA by the Everest Group, they were awarded the Best Digital Health Solution by the Galien Foundation, and they recently collaborated with Tufts CSDD to release the first financial modeling showcasing the benefits of DCTs. Medable DCTs have now demonstrated net financial benefits of up to 5x & 14x greater than the initial upfront investment required for phase II & phase III studies, respectively.
Find out how Medable can partner with your organization to modernize research, replacing outdated processes with an intelligent, unified ecosystem of clinical trial technologies that slash timelines by >50%. Please visit www.Medable.com for further information.
FEATURED CONTENT
-
![eCOA-clinical-GettyImages-1331758896]( "Why The Everest Group Named Medable A Leader In eCOA")
Discover how this eCOA is leading the charge in accelerating study timelines, boosting patient engagement, and answering real sponsor needs.
-
![custom-ai-agents-GettyImages-2160199080]( "Build Or Buy: Adopting AI Agents In Life Sciences")
Should your team build custom AI agents from scratch or partner with a ready-made solution? This practical guide cuts through the hype to reveal the strategic insights you need.
-
![agenic-ai-GettyImages-2245878087]( "Agentic AI Is Transforming Life Sciences Discovery And Operations")
73% of pharma companies are planning or deploying agentic AI. Discover who’s leading and how intelligent agents are transforming R&D.
-
![patient-voice-GettyImages-1367871743]( "FDA Pushes For Patient Voice: ePRO In Oncology Trials")
FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.
-
![GettyImages-1543830891-direct-to-patient-cell-medicine-order-medication]( "Driving A High-Adherence LTFU Trial Without An EDC")
Discover how our partnership with a client was able to deliver a ten-year long-term follow-up (LTFU) trial that delivered an over 90% adherence rate while keeping trial costs low by not using an EDC.
-
![GettyImages-1205564882-staircase-build-blocks-pieces-tetris]( "Building Blocks: The Ultimate Guide To AI In Clinical Trials")
This comprehensive guide provides an authoritative, in-depth look at AI's role in accelerating drug development and improving patient outcomes, with special focus on emerging agentic AI technologies.
-
![Getty Images_ 2156307947_medical-trial-coding-clinical]( "A New Take On The Evolving Role Of AI In Clinical Trials")
Artificial intelligence is shifting from promise to practice in biopharma. Zhong Lu, director of data science and AI at Novartis, outlines how AI is evolving the clinical trials process end-to-end.
-
![Artificial intelligence, AI, digital-GettyImages-2151606282]( "Reclaiming Your Time: How Sponsors Can Save Thousands Of Hours With Agentic AI")
Reimagine the clinical trial lifecycle by automating slow, manual workflows, removing barriers in the clinical process, and introducing new ways to achieve R&D goals like never before.
-
![GettyImages-635978124 research computer]( "Eliminate Clinical Trial White Space With The Right AI Strategy")
Learn how sponsors and CROs are using agentic AI to eliminate the unproductive time caused by manual, sequential processes and fragmented data systems.
-
![laboratory scientist laptop GettyImages-1302454417]( "6 Steps To Help You Choose The Right Clinical Trial Partner")
The right digital partner can unlock speed, scale, and collaboration that can transform the future of your pipeline. Learn the six steps to help you choose the right partner for your trials.
-
![GettyImages-1646106148-AI-pharma-healthcare]( "AI In Clinical Trials: Key Insights From Industry Experts")
Find out what experts from the FDA are saying about AI’s ability to demonstrably impact three critical success metrics in clinical trials.
-
![Removing translation]( "Removing Translation Bottlenecks With AI")
See how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.
-
![GettyImages-2154674637-AI-hand-software-ripple]( "Agentic AI And How It's Impacting Clinical Trial Research")
Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound.
-
![fact and myth-GettyImages-1537534263]( "The Top 5 Myths About eCOA In 2025")
Projected to grow 16.1% annually through 2030, eCOA solutions are booming. Uncover the top five myths and misconceptions about eCOAs in 2025 so your clinical teams can make evidence-based decisions.
-
![GettyImages-1751848523-meeting-evaluation-charts-table]( "Accelerating CRO Study Deployment At Scale")
A top-3 CRO and a top-10 pharmaceutical company partnered with Medable to help accelerate, scale, and standardize their eCOA trials. See how they accomplished it.
-
![GettyImages- 1180547354 trial data]( "No More Back And Forth: Building eCOAs Right The First Time")
Clinical trial system builds have long been plagued by inefficiencies, miscommunications, and long timelines. Learn about a platform helping sponsors and CRO's overcome these challenges.
-
![GettyImages-1385471311 patient tablet]( "CRO Takes Trial Build Times From Weeks To Days")
Recognizing the inefficiencies in traditional build processes, a top global CRO partnered with Medable to transform its approach to clinical trial launch.
-
![GettyImages-2155531148 electronic data, ePRO, eCOA]( "Why ePROs In Oncology Are Perfect For Capturing The Patient's Voice")
Recently released FDA guidance showcases why electronic patient-reported outcomes (ePROs) are ideal for capturing the “voice” of the patient. See how ePRO eases oncology trials.
-
![Artificial intelligence, AI-GettyImages-1168866494]( "Key AI Trial Insights From Regulators And Consultants")
AI’s transformative impact promises more efficient, cost-effective, and successful clinical trials across the pharmaceutical landscape.
-
![iStock-1074203146-computer-typing-work]( "Setting A New Client Standard In Study Closeout Timelines")
Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.
CONTACT INFORMATION
Medable
525 University Ave, Suite A70
Palo Alto, CA 94301
UNITED STATES
FEATURED SOLUTIONS
-
![GettyImages-1326241306-research-computer-brain-scan]( "The Big Impact Of Medable AI")
Streamline your clinical trial study creation by automating and accelerating the eCOA build process. Generative AI models perform your repetitive configurations and significantly shorten build times.
-
![medable studio thumb]( "Medable Studio")
More than just a builder, Medable Studio offers unmatched control over study creation and launch, eliminating the common roadblocks of study startup and empowering users throughout the process.
-
![GettyImages-1372091146 patient ipad]( "Improving The Patient Experience With Total Consent")
Increased outreach, heightened involvement, superior quality. Tour this comprehensive consent management solution that enhances participant access and improves the overall patient experience.
-
![GettyImages-1304430076 oncology ps]( "Patient-First Solutions For Oncology")
Stay connected with your patients and their data by simplifying collection for sites and sponsors while keeping participants safe, comfortable, and engaged from any location.
-
![Novel therapeutics: gene and cell therapies, nanoparticles, and combination]( "Medable Therapeutic Area Pathways")
Accelerate research and drive operational efficiencies with multi-modal, scalable digital solutions for oncology, vaccine, and cardiovascular / metabolic studies.
-
![person using ipad iStock-1029343476]( "Medable eCOA")
Medable eCOA is designed to enhance your decentralized trial capabilities with all features native to the platform. Modular by design, use what you need, not what you don’t.
-
![Preparing For eConsent - A Step By Step Guide For Site Personnel]( "eConsent: Optimize Access")
Learn how to optimize patient access to clinical research with a modern eConsent platform that delivers an engaging, flexible and scalable user experience.
WEBINARS
-
![Medable eCOA webinar]( "Transforming Oncology Trials With Next-Gen eCOA")
With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.
-
![top 5 myths about eCOA]( "The Top 5 Myths About eCOAs In 2025")
Join leading clinical experts as they debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter decisions.
-
![Oncology Cell]( "Defining And Implementing The Right Oncology Digital Strategy")
A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.
-
![check computer for vitals-GettyImages-1446748436]( "Maximize Control And Transparency On The Path To Study Go-Live")
Simplify the historically complicated, black-box processes around eCOA solution deployment, content storage and visualization, and global go-live.
-
![The New Era Of Evidence Generation In Clinical Trials]( "The New Era Of Evidence Generation In Clinical Trials")
Learn how top pharmaceutical companies are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.
-
![medable tech overload thumb]( "Technology Overload: Addressing Site Challenges Of Digital Trials")
Watch as speakers explore the experiences of sites conducting digital and hybrid trials, discussing the critical benefits of a change management strategy and a unified digital trial platform.
-
![amplifying evidence medable web thumb]( "Amplifying Evidence With Unified Clinical Trial Data Collection")
In this presentation, we explore the transformative potential of integrating a unified clinical trial data collection platform with intelligent automation, challenging the inadequacies of the status quo.
-
![medable econsent web thumb]( "What It Really Takes To Adopt eConsent Across Large Pharma")
Explore the benefits of incorporating consent management technology and discover practical strategies for developing effective change management and training programs.
-
![an honest assessment medable web thumb]( "An Honest Assessment Of eCOAs From A Site Perspective")
Listen to what sites have to say about the changing nature of COAs in clinical trials, including the usage of eCOA, its benefits, and ways to improve the technology.
-
![medable tech overload webinar snip 2 thumb]( "Addressing Site And Sponsor Challenges In Digital Trials")
<p>While the digital transformation of clinical trials has made tremendous strides in recent years, the plethora of new technologies can overwhelm. Learn how to help sites and sponsors combat the overload of technology.</p>
-
![medable supercharge webinar thumb]( "How To Supercharge RWE Generation In Phase IV Trials")
Watch as speakers discuss their joint efforts in implementing patient-centric digital trial solutions that harness the potential of RWD, translating it into actionable Real-World Evidence insights for a sponsoring client.
-
![GettyImages-1141776223 oncology]( "Enhancing Oncology Clinical Trials Through The Use Of Digital Technologies")
The most difficult clinical research just became more challenging. Learn tactics on how teams can simplify oncology research while solving new and old issues.
-
![total_consent_adoption_feb_22_presentation_rev]( "Everything You Need To Know About Adopting eConsent Across Large Pharma Organizations")
Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.
-
![medable webinar 1]( "Digital Versus Digitized: Common Misconceptions About eConsent")
In this on-demand webinar attendees will learn about the common misconceptions surrounding eConsent, as well as the benefits they can realize through a digitally-enabled approach.
-
![medable econsent webinar]( "Agile eConsent: Taking A Flexible Approach To Global Implementation")
Hear from industry experts on how they successfully combined agile eConsent technology with global regulatory expertise to increase enrollment rates and reduce both site and patient burden.
-
![Data Analytics Strategy]( "Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy")
In this free webinar, learn how to update your clinical data strategy that ensures you can scale trials globally while decreasing the overall burden on sites and patients.
-
![Pharma Data GettyImages-1091887430]( "Collect Better Oncology Trial Data, Easier")
In this webinar, experts discuss how enriching oncology clinical trials with RWD generates deeper insights and improves operational efficiency to achieve better patient outcomes.
-
![GettyImages-1311429557-vaccine-shot]( "The New Vaccine Race: Why A Decentralized Approach Wins")
What does it take to get vaccine trials up and running quickly and efficiently? As it turns out, the best answer is DCT. Learn why in the available webinar.
